Research Article
A 5-lncRNA Signature Associated with Smoking Predicts the Overall Survival of Patients with Muscle-Invasive Bladder Cancer
Table 3
Correlations between the risk score of the 5-lncRNA signature and clinicopathological characteristics.
| Variable | Low-risk group () | High-risk group () | Pearson | value |
| Age of diagnosis | | | 1.598 | 0.450 | ≤65 | 48 | 46 | | | >65 | 75 | 77 | AJCC T stage | | | 9.315 | 0.009 | T2 | 45 | 25 | | | T3+T4 | 67 | 88 | Lymphonodus status | | | 4.019 | 0.045 | Negative | 82 | 67 | | | Positive | 32 | 46 | Tumor subtype | | | 4.423 | 0.110 | Nonpapillary | 76 | 88 | | | Papillary | 46 | 31 | Pathological stage | | | 4.058 | 0.105 | Stage II+stageIII | 91 | 76 | | | Stage IV | 32 | 47 | Histological grade | | | 16.787 | <0.001 | Low grade | 18 | 1 | | | High grade | 105 | 122 | Family history | | | 0.641 | 0.726 | Yes | 40 | 43 | | | No | 83 | 80 | Smoking statusa | | | 1.112 | | Nonsmoker and smoker for ≤15 years | 53 | 54 | | | Smoker for >15 years | 36 | 30 |
|
|
Statistical significant results (in bold).
|